Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
14.19
+0.07 (0.50%)
Nov 13, 2024, 4:00 PM EST - Market closed
Elanco Animal Health Revenue
Elanco Animal Health had revenue of $1.03B in the quarter ending September 30, 2024, a decrease of -3.56%. This brings the company's revenue in the last twelve months to $4.45B, up 1.99% year-over-year. In the year 2023, Elanco Animal Health had annual revenue of $4.42B with 0.14% growth.
Revenue (ttm)
$4.45B
Revenue Growth
+1.99%
P/S Ratio
1.56
Revenue / Employee
$454,490
Employees
9,800
Market Cap
7.01B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.81B |
Bausch + Lomb | 4.68B |
RadNet | 1.77B |
Halozyme Therapeutics | 947.36M |
Legend Biotech | 520.18M |
Ascendis Pharma | 340.33M |
Cytokinetics | 3.22M |
ELAN News
- 1 hour ago - ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit - PRNewsWire
- 3 hours ago - The Schall Law Firm Invites Shareholders To Join A Case Against Elanco Animal Health Incorporated For Securities Law Violations - Accesswire
- 1 day ago - Elanco Animal Health Incorporated Is Being Sued For Fraud And Impacted Investors Are Encouraged To Contact The Schall Law Firm - Accesswire
- 1 day ago - Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety Profile - Hagens Berman - Accesswire
- 1 day ago - Elanco Animal Health to pay $15 mln to settle SEC fraud case - Reuters
- 1 day ago - Elanco Strengthens Board of Directors with Addition of Stacey Ma - PRNewsWire
- 2 days ago - Elanco (ELAN) Hit with Investor Lawsuit Over New Drug – Hagens Berman - GlobeNewsWire
- 2 days ago - DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - Accesswire